Irritable Bowel Syndrome:  Role of Intestinal Microbiota Disorders  and Ways of Their Correction

I.Ya. Budzak

doi:10.22141/2308-2097.3.49.2013.86339

Irritable Bowel Syndrome: Role of Intestinal Microbiota Disorders and Ways of Their Correction

I.Ya. Budzak

Abstract

The article presents the correlation between intestinal microbiota disorders and irritable bowel syndrome. The mechanisms of pathogenic role of bowel dysbiosis in the development of irritable bowel syndrome were shown. There were analyzed the results of investigations concerning the evaluation of probiotics efficiency in patients with irritable bowel syndrome. The approaches to correction of these disorders were determined.

Keywords

irritable bowel syndrome; bowel dysbiosis; treatment

Full Text:

PDF (Русский)

References

Barbara G., Zecchi L., Barbaro R. et al. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome // J. Clin. Gastroenterol. — 2012 Oct. — 46 Suppl. — S52-5.

Brint E.K., MacSharry J., Fanning A. et al. Differential expression of toll-like receptors in patients with irritable bowel syndrome // Am. J. Gastroenterol. — 2011. — 106. — 329-36.

Cui S., Hu Y. Multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study // Int. J. Clin. Exp. Med. — 2012. — 5(3). — 238-44.

Dapoigny M., Piche T., Ducrotte P. et al. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study // World J. Gastroenterol. — 2012, May 7. — 18(17). — 2067-75.

De Filippo C., Cavalieri D., Di Paola M. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa // Proc. Natl Acad. Sci. USA. — 2010. — 107. — 14691-6.

Ducrotte P., Sawant P., Jayanthi V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome // World J. Gastroenterol. — 2012, Aug 14. — 18(30). — 4012-8.

Dunlop S.P., Jenkins D., Neal K.R. et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS // Gastroenterology. — 2003. — 125. — 1651-9.

Ghoshal U., Shukla R., Ghoshal U., Gwee K., Ng S., Quigley E. The gut microbiota and irritable bowel syndrome: friend or foe? // Int. J. Inflam. — 2012. — 151085.

Kruis W., Chrubasik S., Boehm S. et al. A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome // Int. J. Colorectal Dis. — 2012 Apr. — 27(4). — 467-74.

Longstreth G.F., Hawkey C.J., Mayer E.A. et al. Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials // Aliment. Pharmacol. Ther. — 2001. — 15. — 959-64.

O’Hara A.M., Shanahan F. The gut flora as a forgotten organ // EMBO Rep. — 2006. — 7. — 688-93.

Quigley E., Fried M., Gwee K.A. et al. World Gastroenterology Organization Global Guideline. Irritable bowel syndrome: a global perspective — 2009.

Roberts L.M., McCahon D., Holder R. et al. A randomised controlled trial of a probiotic functional food in the management of irritable bowel syndrome // BMC Gastroenterol. — 2013, Mar 7. — 13. — 45.

Sanders M.E., Guarner F., Guerrant R. et al. An update on the use and investigation of probiotics in health and disease // Gut. — 2013. — 62(5). — 787-96.

Simren M., Barbara G., Flint H.J., Spiegel B.M., Spiller R.C., Vanner S., Verdu E.F., Whorwell P.J., Zoetendal E.G. Intestinal microbiota in functional bowel disorders: a Rome foundation report // Gut. — 2013. — 62. — 159-176.

Suau A., Bonnet R., Sutren M. et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut // Appl. Environ. Microbiol. — 1999. — 65. — 4799-807.

Thabane M., Kottachchi D.T., Marshall J.K. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome // Aliment. Pharmacol. Ther. — 2007. — 26. — 535-44.

Verdu E.F., Bercik P., Verma-Gandhu M. et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice // Gut. — 2006. — 55. — 182-90.

Yoon J.S., Sohn W., Lee O.Y. et al. Effect of multi-species probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial // J. Gastroenterol. Hepatol. — 2013, Jul 5.

DOI: https://doi.org/10.22141/2308-2097.3.49.2013.86339

Refbacks

There are currently no refbacks.

This work is licensed under a Creative Commons Attribution 4.0 International License.

Username
Password
Remember me